Accepted at 7:25 p.m. Mar, 04, 2024 by thomas.holmes
Author: DillingerMed
Related Note: 1474686441354
Rationale for change

UW Step 1 QID 107624 says that Potter syndrome is incorrect terminology. Sequence is due to defects that develop sequentially while syndromes are multiple anomalies that develop independently.

Additional Resources Additional Resources
Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Empty field
One by one
Empty field
#AK_Step1_v12::#AMBOSS::ibaJtQ #PANCE::EOR::Family_med #AK_Step1_v12::#Physeo::09_Pharm::06_Renal::06_ACE_inhibitors #AK_Step1_v12::#UWorld::Step::12262 #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::htn #PANCE::EOR::IM #AK_Step1_v12::#Bootcamp::Nephrology::15_Renal_Pharmacology::06_ACEi,_ARBs,_Direct_Renin_Inhibitors #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::06_Drug_Toxicity #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::26_Integrative_Cardiovascular_Pharmacology_Hypertension_Ischemic_Heart_Disease_and_Heart_Failure #AK_Step1_v12::#B&B::22_Repro::01_Embryology::05_Teratogens_I #PANCE::EOR::EM #AK_Step1_v12::^Systems::Renal::Pharmacology #AK_Step2_v12::#AMBOSS::6xajx5 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::09_Hypertension #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::05_Teratogens #PANCE::CARDIO::hypertension #AK_Step1_v12::#UWorld::#UWSA1 #AK_Step1_v12::#Physeo::09_Pharm::06_Renal::07_Angiotensin_II_Receptor_Blockers #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::01_Heart_Failure_Drugs::02_ACE_Inhibitors,_ARBs,_Aliskiren #AK_Step2_v12::#Bootcamp::Pediatrics::01_Neonatology::05_Teratogen_and_TORCH::01_Environmental_Teratogens #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#NBME::Free120::2024 #AK_Step1_v12::#NBME::Free120 #AK_Step2_v12::#NBME::Form14::Section_2 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::06_Drugs_for_Heart_Failure #AK_Step2_v12::#UWorld::COMLEX::104157 #AK_Step1_v12::#AMBOSS::6xajx5 #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::08_ACE-I_&_ARBs_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::21_Pharmacology_Of_Volume_Regulation #AK_Step2_v12::!Shelf::ObGyn::no_dupes #AK_Step1_v12::#UWorld::Step::6443 #AK_Step1_v12::#Bootcamp::Reproduction::01_Fetal_Development::03_Teratogenic_Medications #AK_Step1_v12::#Pixorize::03_Pharmacology::18_Renal_Pharm::09_Angiotensin_II_Receptor_Blockers_(ARBs) #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#FirstAid::01_Cardiovascular::10_Hypertension::02_Primary_(Essential)_Hypertension #AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives #AK_Step1_v12::#Pixorize::03_Pharmacology::18_Renal_Pharm::01_ACE_Inhibitors #AK_Step1_v12::#SketchyPath::08_Repro_&_GU::03_Gestational_Disorders::03_Polyhydramnios_&_Oligohydramnios #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::04_Antihypertensives_II #AK_Step2_v12::#UWorld::Step::19122 #AK_Step1_v12::#FirstAid::14_Renal::05_Pharm::09_Angiotensin_II_receptor_blockers #AK_Step1_v12::#Bootcamp::Cardiology::10_Renin-Angiotensin-Aldosterone_System::02_Direct_Pharmacologic_Targets #AK_Step1_v12::#FirstAid::14_Renal::05_Pharm::08_Angiotensin-converting_enzyme_inhibitors #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::09_Antihypertensive_Drugs #AK_Step2_v12::#Resources_by_rotation::ObGyn::uw::dorian #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::FM::ome::cardio::htn